US Stocks Result Analysis for Industry - Biotechnology for the month ending Mar 31, 2025
Analysis of which stocks have performed the best and worst in Industry - Biotechnology for the month ending Mar 31, 2025 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current month are considered.
Note: Industry-level growth metrics have been calculated by totaling the numbers of all companies in that industry, to get an average.
MAR-24
12.0 US$ Mn
MAR-25
17.0 US$ Mn
MAR-24
8.6 US$ Mn
MAR-25
7.3 US$ Mn
MAR-24
-3.1 US$ Mn
MAR-25
-1.5 US$ Mn
MAR-24
-3.3 US$ Mn
MAR-25
-3.2 US$ Mn
MAR-24
-11.3 US$ Mn
MAR-25
-6.3 US$ Mn
MAR-24
-2.5 US$ Mn
MAR-25
4.5 US$ Mn
MAR-24
-2.2 US$ Mn
MAR-25
-1.6 US$ Mn
MAR-24
-3.6 US$ Mn
MAR-25
-3.4 US$ Mn
MAR-24
-9.8 US$ Mn
MAR-25
-7.2 US$ Mn
MAR-24
-2.6 US$ Mn
MAR-25
4.5 US$ Mn
| Stock | Market Capitalization | Operating Revenue Qtr | Revenue Growth Qtr YoY % | Revenue Surprise Qtr % | Net Profit Qtr | Net Profit Qtr Growth YoY % | Net Profit Surprise Qtr % | Operating Profit Qtr | Operating Profit Growth Qtr YoY % | EBIDT Qtr | EBIDT Qtr growth YoY % | Operating Profit Margin Qtr % | Operating Profit Qtr Margin% YoY Change | Last Result Updated |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. |
16.77
|
7.33
|
-14.25
|
-
|
-1.54
|
49.85
|
-
|
-1.60
|
26.68
|
0.00
|
-
|
-21.84
|
3.70
|
17-Mar-2025 |
| Anixa Biosciences Inc |
83.07
|
0.00
|
-
|
-
|
-3.18
|
2.18
|
-
|
-3.39
|
6.18
|
0.00
|
-
|
-
|
-
|
11-Mar-2025 |
| BriaCell Therapeutics Corp |
16.14
|
0.00
|
-
|
-
|
-6.29
|
44.30
|
-
|
-7.17
|
27.06
|
0.00
|
-
|
-
|
-
|
12-Mar-2025 |
| Champions Oncology Inc |
101.49
|
17.04
|
41.77
|
31.79
|
4.50
|
277.67
|
965.38
|
4.50
|
274.58
|
0.02
|
109.09
|
26.40
|
47.85
|
17-Mar-2025 |
